Pulmonary Fibrosis
9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Lung Diseases, Lung Diseases, Interstitial
Narrower: Idiopathic Pulmonary Fibrosis 7
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| BC006 for idiopathic pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Belumosudil 200 mg QD for pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bersiporocin for idiopathic pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CAL101 for idiopathic pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Colchicine 0.5 mg for pulmonary fibrosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HB0056 for idiopathic pulmonary fibrosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HSK44459 for idiopathic pulmonary fibrosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rentosertib for idiopathic pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Taladegib for idiopathic pulmonary fibrosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.